Ticagrelor for coronary artery disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 7 registered trials.

Why this status

  1. 5 Dec 2012: Trial registered, NCT01742117
  2. 31 Oct 2020: Trial completed, NCT01742117

The trials

NCT01360437: Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

State
Completed
Phase
Phase 3
People
44 taking part
Started
May 2011
Primary completion
Dec 2011
Arms
Ticagrelor
Results
None posted
Papers
doi:10.1016/j.jacc.2012.03.050
  1. 25 May 2011: Trial registered

NCT01642940: Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study

State
Completed
Phase
Phase 4
People
30 taking part
Started
Jun 2012
Primary completion
Sep 2012
Arms
Ticagrelor
Results
None posted
Papers
doi:10.2337/dc12-2510
  1. 17 Jul 2012: Trial registered

NCT01742117: Tailored Antiplatelet Therapy Following PCI

State
Completed
Phase
Phase 4
People
5,276 taking part
Started
May 2013
Primary completion
31 Oct 2020
Arms
Genotype-Guided Therapy
Results
Posted on the registry
Papers
doi:10.1001/jama.2020.12443, doi:10.1007/s10557-022-07392-2, doi:10.1016/j.jcin.2023.01.356, doi:10.1038/s41397-022-00278-4, doi:10.1111/cts.70655, doi:10.1161/jaha.121.024156, doi:10.1161/jaha.121.024709, doi:10.2196/34080
  1. 5 Dec 2012: Trial registered
  2. 31 Oct 2020: Trial completed
  3. 9 Nov 2021: Trial results posted

NCT01826175: Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study

State
Withdrawn before it started
Phase
Phase 4
People
0 taking part
Started
May 2013
Primary completion
May 2014
Arms
Ticagrelor
Results
None posted
  1. 8 Apr 2013: Trial registered
  2. 20 Dec 2016: Trial withdrawn

NCT02016170: Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

State
Completed
Phase
No phase
People
82 taking part
Started
Mar 2014
Primary completion
Oct 2015
Arms
Ticagrelor 180mg, Ticagrelor 90mg
Results
Posted on the registry
Papers
doi:10.1016/j.jcin.2016.02.039
  1. 19 Dec 2013: Trial registered
  2. 18 Oct 2016: Trial results posted

NCT04060914: LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

State
State not given
Phase
Phase 4
People
225 planned
Started
30 Aug 2019
Primary completion
30 Dec 2020
Arms
Ticagrelor(90mg), Ticagrelor(90/60mg)
Results
None posted
  1. 19 Aug 2019: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Brilinta, Brilique, Chewing Ticagrelor, Possia, Ticagrelor 180mg, Ticagrelor 45 mg, Ticagrelor 60mg, Ticagrelor 90mg, Ticagrelor 90mg for 6-month (immediately after PCI), Ticagrelor 90mg/60mg, Ticagrelor monotherapy, half-dose ticagrelor, low-dose ticagrelor.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.